CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project develops an artificial intelligence-based algorithm called SmartContrast to reduce the dosage of gadolinium in cranial magnetic resonance tomography. This innovation aims to enhance patient safety by minimizing the risks associated with contrast agents while maintaining diagnostic efficacy.
In cranial magnetic resonance tomography (cMRT), the administration of contrast agent facilitates diagnosis of various pathologies such as metastases due to contrast agent enhancement.
Patients undergoing a medically indicated cMRT receive 100% of the authorized contrast agent dose, i.e., 0.1 mmol of gadolinium per kg body weight.
The main component of MRT contrast agent is gadolinium, which is a highly toxic rare-earth element, which has potential health side effects (inter alia allergic reacti…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
